secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001558370-25-011909
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics files updated corporate slide deck; no material new data disclosed
--------------------------------------------------------------------------------

- Filed updated corporate presentation dated September 2025 under Item 8.01.
- Presentation titled 'Precision Oncology Through Synthetic Lethality' continues DDR inhibition focus.
- No specific financial, clinical, or pipeline milestones were evident from the excerpt provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000155837025011909/0001558370-25-011909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000155837025011909/apre-20250908x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-011909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer